ZA9610457B - Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man - Google Patents

Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man

Info

Publication number
ZA9610457B
ZA9610457B ZA9610457A ZA9610457A ZA9610457B ZA 9610457 B ZA9610457 B ZA 9610457B ZA 9610457 A ZA9610457 A ZA 9610457A ZA 9610457 A ZA9610457 A ZA 9610457A ZA 9610457 B ZA9610457 B ZA 9610457B
Authority
ZA
South Africa
Prior art keywords
emesis
sleeps
piperazinyl
heteroaryl
medicament
Prior art date
Application number
ZA9610457A
Inventor
Jordi Frigola-Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of ZA9610457B publication Critical patent/ZA9610457B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA9610457A 1995-12-12 1996-12-12 Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man ZA9610457B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (en) 1995-12-12 1995-12-12 USE OF DERIVATIVES 1- (4- (4-ARYL (OR HETEROARYL) -1-PIPER AZINYL) -BUTY) -1H-AZOLE FOR THE TREATMENT OF DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS, SLEEP APNEA, SEXUAL DYSFUNCTIONS , Emese and motion sickness

Publications (1)

Publication Number Publication Date
ZA9610457B true ZA9610457B (en) 1997-06-24

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9610457A ZA9610457B (en) 1995-12-12 1996-12-12 Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man

Country Status (16)

Country Link
EP (1) EP0808166A1 (en)
JP (1) JPH11501051A (en)
CN (1) CN1177297A (en)
AR (1) AR004378A1 (en)
AU (1) AU716665B2 (en)
CA (1) CA2211161A1 (en)
CZ (1) CZ255197A3 (en)
ES (1) ES2134709B1 (en)
FR (1) FR2742052B1 (en)
HU (1) HUP9800198A2 (en)
IL (1) IL121461A0 (en)
NO (1) NO973589L (en)
PL (1) PL321779A1 (en)
TR (1) TR199700794T1 (en)
WO (1) WO1997021439A1 (en)
ZA (1) ZA9610457B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (en) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4- (4,5-DICHLORO-2-METHYLIMIDAZOL-1-YL) BUTYL] -1- PIPERAZINYL} -5-FLUOROPYRIMIDINE, ITS PREPARATION AND THERAPEUTIC USE
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
AU8125501A (en) 2000-08-14 2002-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
MXPA03001420A (en) 2000-08-14 2004-01-26 Johnson & Johnson Substituted pyrazoles.
DK1309593T3 (en) 2000-08-14 2006-07-17 Ortho Mcneil Pharm Inc Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
US6579896B2 (en) 2000-09-06 2003-06-17 Ortho-Mcneil Pharmaceutical, Inc. Method for treating allergies using substituted pyrazoles
WO2005030148A2 (en) 2003-09-25 2005-04-07 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
BRPI0610258A2 (en) 2005-04-26 2012-09-25 Hypnion Inc compound or a pharmaceutically effective salt thereof, pharmaceutical composition, and use of a compound
DE602006012650D1 (en) * 2005-04-26 2010-04-15 Hypnion Inc BENZISOXAZOLPIPERIDIN COMPOUNDS AND METHOD FOR THE APPLICATION
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590A (en) * 2022-09-19 2022-11-08 皮摩尔新药(辽宁)有限公司 2H-benzotriazole derivatives, preparation method thereof and pharmaceutical composition containing same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (en) * 1991-01-28 1995-05-24 Esteve Labor Dr DERIVATIVES OF ARYL (OR HETEROARYL) -PIPERAZINYL-ALKYL-AZOLES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
FR2723091B1 (en) * 1994-07-29 1996-11-08 Esteve Labor Dr TETRAHYDROPYRIDINE- (6,4-HYDROXYPIPERIDINE) ALKYLAZOLES

Also Published As

Publication number Publication date
IL121461A0 (en) 1998-02-08
FR2742052B1 (en) 1998-04-10
PL321779A1 (en) 1997-12-22
CN1177297A (en) 1998-03-25
NO973589L (en) 1997-10-08
EP0808166A1 (en) 1997-11-26
CZ255197A3 (en) 1998-01-14
ES2134709A1 (en) 1999-10-01
TR199700794T1 (en) 1997-11-21
AU1376497A (en) 1997-07-03
FR2742052A1 (en) 1997-06-13
ES2134709B1 (en) 2000-05-16
AU716665B2 (en) 2000-03-02
MX9706133A (en) 1997-11-29
CA2211161A1 (en) 1997-06-19
WO1997021439A1 (en) 1997-06-19
NO973589D0 (en) 1997-08-04
JPH11501051A (en) 1999-01-26
HUP9800198A2 (en) 1999-09-28
AR004378A1 (en) 1998-11-04

Similar Documents

Publication Publication Date Title
GB9521537D0 (en) Device and method for the treatment of sleep apnea syndrome
ZA9610457B (en) Use of 1(4-(aryl(or heteroaryl)-1-piperazinyl)-1H-azole derivatives for the preparation of a medicament for use in the treatment of compulsive obsessive disorders sleeps apnoea syndrome sexual dysfunctions emesis and travel sickness in mammals including man
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
HUP0002645A3 (en) Phospholipid containing pharmaceutical composition for treating sleep apnea and apparatus for enabling the administration thereof
HUP0102656A3 (en) N-substituted aminotetralins as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders and medicaments containing them
HUP0103654A2 (en) Use of smilagenin and anzurogenin-d for production of pharmaceutical compositions for the treatment of alzheimer's disease
AP2001002102A0 (en) Pharmaceutical agents for the treatment of parkinson's disease and adhd and microadenomas
FI953915A (en) For the relief of Dupuytren's disease
AU3279395A (en) Methods for treating and/or preventing alzheimer's disease using phenothiazines and/or thioxanthenes
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
HUT62192A (en) Process for producing pharmaceutical compositions comprising tomoxetine and suitable for treating diseases of lower urinary tract
PL368804A1 (en) 4(piperidin-4-yliden-(3-carbamoylphenyl)methyl] benzamide derivatives and their use for the treatment of pain, spinal injuries or gastrointestinal disorders
CA2295119A1 (en) Use of a specific antagonist of 5ht2 receptors for preparing medicines useful for treating sleep-disordered breathing
IL117695A0 (en) Pharmaceutical agents for the treatment of alzheimer's disease
GR3015716T3 (en) Use of buspirone in sleep apneas.
HUP9802736A3 (en) Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls
NO996060D0 (en) Breathing apparatus for the treatment of sleep apnea
ITRM940806A0 (en) PREPARATION FOR THE TREATMENT OF OBESITY
AU8195091A (en) Ropinirole and domperidone for use in the manufacture of a medicament for the treatment of parkinson's disease
AU2137595A (en) Use of arylpiperazine derivatives for the treatment of Parkinson's disease and psychosis
AU4834896A (en) Oral device for the prevention of snoring and sleep apnoea
EP0862442A4 (en) Methods for diagnosis and treatment of bloom's syndrome
HUP0000476A3 (en) Use of 17 betha-dihydroequilenin for producing pharmaceutical compositions for the treatment of free radical induced disease states
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders
AU3142793A (en) Transdermal delivery of (E)-1,2,5,6-tetrahydro-1-methyl-3-pyridine-carboxaldehyde-O- methyloxine HCL and related compounds in the treatment of cognitive disorders and for analgesia